Reoperative central neck surgery

Similar documents
4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer

Persistent & Recurrent Differentiated Thyroid Cancer

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Review Article Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Avi Khafif, MD, Rami Ben-Yosef, MD, Avrum Abergel, MD, Ada Kesler, MD, Roee Landsberg, MD, Dan M. Fliss, MD

Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

The role of prophylactic central compartment lymph node dissection in differentiated thyroid carcinoma

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

Dr J K Jekel Dept. Surgery University of Pretoria

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer

Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

Differentiated Thyroid Cancer: Initial Management

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016

Accepted 12 August 2013 Published online 27 November 2013 in Wiley Online Library (wileyonlinelibrary.com). DOI /hed.23451

Current Issues in Thyroid Cancer Surgery in 2017

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary

Surgery for Recurrent Thyroid cancer: Considerations and limitations

Central Lymph Node Dissection In Patients With Papillary Thyroid Cancer: A Population Level Analysis Of Cases

Preoperative Evaluation

Gerard M. Doherty, MD

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

Research Article A Study on Central Lymph Node Metastasis in 543 cn0 Papillary Thyroid Carcinoma Patients

Thyroid Neoplasm. ORL-Head and neck Surgery 2014

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting?

PEDIATRIC Ariel Katz MD

Management of Recurrent Thyroid Cancer

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information

Thyroid Cancer. With 51 Figures and 30 Tables. Springer

Frequency and pattern of central lymph node metastasis in papillary carcinoma of the thyroid isthmus

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

ORIGINAL ARTICLE. The Importance of Central Compartment Elective Lymph Node Excision in the Staging and Treatment of Papillary Thyroid Cancer

Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

ORIGINAL ARTICLE. Incidental Parathyroidectomy During Thyroid Surgery Does Not Cause Transient Symptomatic Hypocalcemia

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.

Intermittent intraoperative nerve monitoring in thyroid reoperations: Preliminary results of a randomized, single-surgeon study

Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update

Downloaded from online.liebertpub.com by UT Southwestern Medical Center at Dallas on 01/03/15. For personal use only.

Research Article Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis

Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence

Department of Surgery, Eulji University College of Medicine, Seoul, Republic of Korea 2

The clinical prognosis of patients with cn0 papillary thyroid microcarcinoma by central neck dissection

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

New technologies in Endocrine Surgery

WTC 2013 Panel Discussion: Minimal disease

Calcitonin. 1

Central and lateral neck dissection for differentiated thyroid cancer Diferansiye tiroid kanserlerinde santral ve lateral boyun diseksiyonu tekniği

B Berry, J. 25 see also suspensory ligament of Berry biopsy see fine-needle aspiration biopsy (FNAB); open wedge biopsy

Context: Diffuse sclerosing variant (DSV) is a rare and aggressive subtype of papillary thyroid carcinoma (PTC).

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

Volume 2 Issue ISSN

Operative bed recurrence of thyroid cancer: utility of a preoperative needle localization technique

Elective Central Compartment Neck Dissection in Patients With Papillary Thyroid Carcinoma Recurrence

Long Term Follow-Up for Differentiated Thyroid Cancer: The Mayo Experience

C. BELLOTTI, G. CASTAGNOLA, S.M. TIERNO, F. CENTANINI, A. SPARAGNA, I. VETRONE, G. MEZZETTI. Introduction. Patients and Methods

Introduction. Materials and methods Y-N XU 1,2, J-D WANG 1,2

A Closer Look at Parathyroid Anatomy During Thyroid Surgery

Changing trends in the management of well-differentiated thyroid carcinoma in Korea

1. Introduction. 2. Patients and Methods

Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid

Tumor location dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer

What? When? Why? (How?)

ORIGINAL ARTICLE. Changing Trends and Prognoses for Patients With Papillary Thyroid Cancer

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis

Reference No: Author(s) Approval date: October committee. September Operational Date: Review:

Surgical anatomy of thyroid and parathyroid glands

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S.

Lang, BHH; Lee, GCC; Ng, CPC; Wong, KP; Wan, KY; Lo, CY. Citation World Journal of Surgery, 2013, v. 37 n. 12, p

An Unexpected Cause of Hypoglycemia

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits?

T here are four parathyroid glands, which are located

Case Papillary thyroid carcinoma(ptc):local recurrence post thyroidectomy

5/18/2013. Most thyroid nodules are benign. Thyroid nodules: new techniques in evaluation

Thyroid Cancer: Imaging Techniques (Nuclear Medicine)

Management of the neck in differentiated thyroid cancer

Research Article Papillary Thyroid Cancer, Macrofollicular Variant: The Follow-Up and Analysis of Prognosis of 5 Patients

Thyroid nodules. Most thyroid nodules are benign

Adjuvant therapy for thyroid cancer

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease

2. Patients & Methods

Clinical Guidance in Thyroid Cancers. Stephen Robinson Imperial at St Mary s On behalf of BTA

Background. Methods. Results

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

YCN Thyroid NSSG. *** VALID ON DATE OF PRINTING ONLY - all guidelines available at *** page 1 of 8 version number: 1.

PAPER. Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer

Transcription:

Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University Sofia

Central compartment Common site of local metastases s for thyroid carcinoma. Reoperation - significant challenge even to the most accomplished surgeon. Recurrence - is difficult to treat surgically and may become complicated

Central compartment lymph nodes are composed of: perithyroidal, pretracheal, paratracheal, prelaryngeal, delphian, tracheoesophageal, and anterosuperior mediastinal nodes. trachea, Recurrent L Nerve, great vessels are located in the central compartment.

Surgical debate, in the management of thyroid cancer is the extent of surgery Total vs near-total thyroidectomy Extent of associated lymph node dissection, particularly in (PTC) To improve staging, and to avoid complications related to reoperation,, some surgeons advocate routine prophylactic CLND. Large retrospective studies have failed to identify LNMs as an important prognostic factor

Reoperative central neck surgery extent of central dissection therapeutic efficacy potential risks.

Most thyroid carcinomas (75%( 75%-85%) are papillary thyroid carcinoma (PTC), which has an excellent overall prognosis!! It t is important to compare the therapeutic effects of more or less aggressive CLND. More aggressive CLND, may increase the incidence of postoperative complications, including injury of the RLN and hypoparathyroidism

Clinical significance of central compartment differs, from that of the lateral compartment Frequency of lymph node metastasis in 759 patients with PTC to determine whether and how such metastasis affects disease-free survival (DFS). Central node metastasis was observed in 63% of patients, and the frequency was increased in relation to tumor size On multivariate analysis of cases showing tumor larger than 1 cm, central node metastasis was recognized as an independent prognostic factor of DFS Clinical Significance of Lymph Node Metastasis of Thyroid Papillary ary Carcinoma Located in One Lobe World Journal of Surgery 2006 Y. Y Ito, T.Jikuzono, T. T Higashiyam et al.

Clinical significance of the central compartment The most frequent LNMs - are in the central compartment,, especially in the side ipsilateral to the tumor,, followed by the ipsilateral compartment. Metastatic spread to the contralateral and mediastinal compartments is uncommon and late. Is central neck dissection a safe procedure in the treatment of PTC?? Our experience. Langenbeck's Archives of Surgery 2008, Volume 393, Number 5, 693-698; 698; N. Palestini, A. Borasi, L. Cestino, et al

Pattern of Nodal Metastasis for Reoperative Thyroid Cancer Distribution of Nodal Metastasis of Compartments by pt Category for Reoperative Thyroid Carcinomas PTC- the ipsilateral cervicolateral compartment was involved almost as often as the cervicocentral compartment (21%( vs. 37%) MTC - the cervicocentral compartment was affected more often than the ipsilateral cervicolateral compartment (65%( vs. 49%). Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer World J. Surg. 26, 22 28, 28, 2002; A. Machens, R. R Hinze, O. Thomusch, H. H Dralle,

Preoperative Diagnosis of perisitent / recurrent TC Ultrasonography,, MRI, CT, I131 WBS?

Preoperative Diagnosis Ultrasonography When used u before a subsequent operation for PTC,, US had a true-positive rate of 56.7%, a true-negative rate of 13.8%, a false-positive rate of 3.7%, and a false-negative rate of 6.0%. US displayed 90.4% sensitivity, 78.9% specificity, 93.9% positive predictive value,, and overall 87.9% accuracy. Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer. Arch Surg. 2006;141:489-496 496; John M. Stulak; Cl. Grant, D. Farley, et al:

Reoperative central neck surgery nodes don't matter??? Indications: include primary thyroid cancer recurrence and/or metastases to the paratracheal and mediastinal lymph nodes Technically: more difficult because of presence of scar tissue and disruption of normal anatomy, greater risk of injury to RLN and parathyroid glands Staff: Experienced thyroid surgeons with knowledge of surgical techniques.

Reoperative central neck surgery Should be followed an algorithm? Goal: safe and effective removal of recurrent / persistent disease. This algorithm should include: - systematic review of prior operative notes, pathology notes, and imaging studies - for localization of disease, - understanding of reoperative central neck anatomy, - appreciation for disease behavior Reoperation for recurrent / persistent well-differentiated thyroid cancer Otolaryngol Clin North Am. 2010 Apr;43(2):353-63, Pai SI, Tufano RP

Reoperative central neck surgery Surgical Technique - our experience Microdissection technique: : using optical magnification and bipolar coagulation Kocher incision- extended laterally for or adequate exposure, (but not along the sternocleidomastoid muscle)

Reoperative central neck surgery Surgical Technique - our experience The LRNs were identified - where they cross the inferior thyroid artery and were exposed upwards until their insertion in the larynx. In the CND procedures, one or both LRNs were prepared caudally until the mediastinum.

Reoperative central neck surgery Surgical Technique- our experience The parathyroid glands were preserved in situ with their vascular pedicle. Transcervical Thymectomy was performed only when radical excision was required

Therapeutic effects of surgical treatment Patients were considered disease-free if during follow- up thyroglobulin levels were undetectable,, and I131 scintigraphy during TSH stimulation, was negative. Postoperative follow-up for recurrent PTC increasingly includes thyrotropin-stimulated thyroglobulin and high-resolution ultrasonography (US). This combination commonly can detect recurrent disease as small as 5 mm. Staging of patients was in accordance with the 6th edition of the TNM system.

Complication rates Reoperative CLND is an uncommon operation with associated morbidity! Incidence of permanent RLN Visual or Neuro-monitoring monitoring, RLN paralysis - ranging from 1% to 12% Meticulous surgical dissection, Additional surgical strategies were used to decrease injury to the RLN: - identification of each nerve low in the tracheoesophageal groove distant from the thyroid bed and - an inferior-to to-superior dissection during the CLND

Complication rates: Hypoparathyroidism - Temporary hypoparathyroidism from 0.3% to 49.0%, in several large series - Permanent hypoparathyroidism - from 0% to 13%. - The specimen should be carefully examined for parathyroid tissue!!! - Reimplantation of the parathyroid glands at the time of reoperative CLND is of questionable viability - fibrosis and multiple positive lymph nodes in the dissected specimen can make identification and confirmation of parathyroid tissue difficult.

Reoperative central neck surgery included Preoperative evaluation clinical history with complete physical examination, routine laboratory evaluation, cervical ultrasound determination for neck lymph nodes, fine needle aspiration biopsy (FNAB),

Reoperative central neck surgery (n=141) our experience (n=141) Between 2002 and 2011-141 patients underwent central compartment reoperation for recurrent or metastatic thyroid cancer and completion TH All patients had prior total-, subtotal- or hemithyroidectomy, and 27 patients had prior neck dissections 45 patients had received radioactive iodine therapy 5 months to 11 years prior to their reoperation for recurrent thyroid cancer.

Reoperative central neck surgery our experience (n=141) Completion thyroidectomy - in 56 cases (32 CLND) scheduled of > 3 months, after primary surgery Primary recurrence in thyroid bed- in 12 patients (7 CLND) Evidence of LND metastases - paratracheal or mediastinal in 65 patients Histology: MTC in 21 patients, FTC in 8 patients, PTC in 112 patients follicular variant of PTC in 333 patients, tall cell variant PTC in 5 patients.

Reoperative central neck surgery our experience (n=141) full central compartment lymph node dissection (left and right thyroid beds) - performed in 34 patients a right CLND in 29 patients, a left CLND in 32 patients and node picking in 9 patients The mean number of lymph nodes removed was 9.0,, and the mean number of positive lymph nodes was 4.7 One experienced thyroid surgeons (RP)) carried out all operations

Postoperative morbidity our experience (n=141) Of the 126 patients with normal preoperative parathyroid function, 33 patients (26%) developed transient postoperative hypocalcemia Permanent hypoparathyroidism - 4 (3.2%) patients Transient RLN palsy 4 (3%) patients There was One case (0.7%) of permanent RLN injury

Follow-up up (median 6 years) our experience (n=141) A total of 73 (52%) patients are currently living without evidence of disease after their reoperative CLND. 64 patients s (45%) - alive with evidence of disease (14 MTC, 58 PTC) disease-specific specific mortality 4 patients (3%) (11 FPTC, 3 MTC)

Diminishing the need for reoperation is important!!! At the initial surgical procedure - Complete removal of the primary thyroid cancer and involved regional lymph nodes will lessen the need for reoperation. On the other hand, large number of the patients underwent insufficiently extensive surgery

Does prophylactic CLND improve the prognosis of PTC patients? JSTS/JAES ATA American Thyroid Association BTA British Thyroid Association NCCN National Comprehensive Cancer Network AACE/AAES Routinely recommended May be performed for T3 or T4 patients Male gender, age >45 years, tumor size >4 cm, extracapsular or extrathyroidal disease Can be considered for patients <15 years old or >45 years old, radiation history, distant metastasis, bilateral nodularity, extrathyroidal extension, tumor size >4 cm, and aggressive variant Not recommended Therapeutic Strategy for Differentiated Thyroid Carcinoma in Japan Based on a Newly Established Guideline Managed by JS Thyroid Surgeons and JA Endocrine Surgeons. World Journal of Surgery (2011) 35: 111 121; H.Takami, Y. Ito, T. Okamoto ey al.

Is additional a Central Neck surgery recommended? Large retrospective studies evaluating the prognostic factors have demonstrated that the presence of lymph node metastases in patients with PTC is not associated with a decrease in survival When factors - age and vascular invasion are controlled, the presence of lymph node metastases lead to an overall decrease in survival. Lymph node metastases have been associated with an increased incidence of locoregional recurrence There is no room for argument that therapeutic central node dissection is mandatory.

Conclusions Adequate preoperative imaging with precise anatomical localization - mandatory in the management of reoperative PTC patients Meticulous surgical dissection with identification of the RLN and preservation of the parathyroid glands safeguards against injury to these structures. Of greater importance is the surgeon's responsibilities - Failure to excise the LNDs, reflects as surgeon indifference or as surgeon inexperience.